2025 - Introduced
Indiana H.B. 1358
  • Prohibits stricter coverage restrictions under Medicaid and the Children’s Health Insurance Program for FDA-approved non-opioids compared to opioids to treat or manage pain. The bill also prohibits health insurers and health maintenance organization contracts from applying greater coverage restrictions on non-opioid prescribed drugs than to opioid drugs.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Iowa HSF 151
  • Requires that a non-opioid drug approved by the FDA is not disadvantaged or discouraged with respect to Medicaid coverage relative to an opioid on the preferred drug list.
  • Prohibits health insurers from establishing utilization controls for non-opioid drugs approved by the FDA that are more restrictive or extensive than the least restrictive or extensive utilization controls for any opioid.
Medicaid ParityState Regulated Commercial Parity
Read Bill
2025 - Introduced
Kansas H.B. 2364
  • Requires state health programs to cover non-opioid pain medications without requiring patients to try opioids first and without less favorable coverage or higher cost-sharing than opioids.
  • Prohibits formularies from disadvantaging FDA-approved non-opioid pain treatments through stricter utilization controls or tier placement.
Medicaid ParityState Employee Health Plan Parity
Read House Bill
2026 - Introduced
Kentucky S.B. 56
  • Prohibits the Kentucky Department for Medicaid Services, Medicaid managed care organizations, and the Medicaid pharmacy benefit manager from denying coverage of a prescribed non-opioid in favor of an opioid drug for the treatment of acute pain.
Medicaid Parity
Read Senate Bill
2025 - Introduced
Kentucky S.B.128
  • Prohibits Medicaid from denying coverage for a non-opioid in favor of an opioid or establishing more restrictive or extensive utilization controls for non-opioids than the least restrictive or extensive utilization controls for any opioid.
Medicaid Parity
Read Bill
2024 - Passed
Louisiana S.B. 224
  • Directs that the state Medicaid program may not impose more restrictive utilization controls for non-opioid drugs than for opioids.
  • Prohibits Medicaid managed care organizations from denying coverage for a non-opioid prescription prescribed for pain in favor of an opioid.
  • Directs the state to create education, awareness and technical assistance materials on the advantage of non-opioid drugs and provide assistance with grants that promote non-opioid pain drugs.
EducationMedicaid Parity
Read Bill
2024 - Passed
Maine L.D. 2096
  • Requires health insurers develop and submit a plan to the Maine Bureau of Insurance for review and approval of the inclusion of non-opioid pain management services and treatments. Upon approval, insurers must develop and disseminate related educational materials.
State Regulated Commercial ParityEducation
Read Bill
2025 - Introduced
Maryland H.B. 1013/S.B. 974
  • Prohibits prior authorization requirements, step therapy protocol, or fail-first protocol for a non-opioid that is more restrictive than requirements for an opioid.
Medicaid ParityState Regulated Commercial Parity
Read House BillRead Senate Bill
2025 - Introduced
Massachusetts H.1134/S.863
  • Requires MassHealth (Medicaid) and its contracted plans to cover FDA-approved non-opioid pain medications on parity with opioids by prohibiting more restrictive coverage, prior authorization, or step therapy requirements.
  • Expands Medicaid chronic pain care through integrated services, quality strategies, provider training, and statewide data collection and reporting on chronic pain prevalence and costs.
Medicaid Parity
Read House BillRead Senate Bill
2024 - Passed
Massachusetts H.5142
  • Requires health insurers to cover non-opioid medications without favoring opioids over non-opioids.
  • Requires the Massachusetts Department of Health create educational materials about non-opioid treatments for use at pharmacies, as well as develop new provider training requirements regarding non-opioid alternatives for pain treatment.
State Regulated Commercial ParityProvider Education
Read Bill
2025 - Introduced
Michigan S.B. 551
  • Requires Michigan Medicaid to cover non-opioid pain medications and add them to the preferred drug list within 90 days.
  • Prohibits prior authorization and expands existing Medicaid protections that exempt certain drugs from prior authorization.
Medicaid Parity
Read Senate Bill
2025 - Introduced
Michigan S.B. 552
Requires health insurers to cover at least one non-opioid drug for pain management on the state preferred drug list.
State Regulated Commercial Parity
Read Bill